Alverno Laboratories
Clinical Test Bulletins

Dear Healthcare Provider,
The information contained here may be very important to your practice. Please take a moment to review this document.


September 5, 2019
If you order Lupus Anticoagulant testing, please read the information regarding changes listed on page 2.


September 18, 2019
In accordance with CDC guidelines, the U.S. Occupational Safety and Health Administration (OSHA) Lead Standards, and the “Recommendations of Medical Management of Adult Lead Exposure, Environmental Health Perspective, 2007,” Alverno Laboratories will be updating its critical value reporting for lead testing. The new critical values can be seen in the table below. Lead values will continue to be reported to the State Department of Public Health as well.


Lupus Anticoagulant Testing

September 5, 2019
As of September 5, 2019, Alverno will be inactivating our current Lupus Screen and redirecting all Lupus Anticoagulant testing to ARUP. The ARUP Lupus Anticoagulant Reflexive Panel utilizes the International Society on Thrombosis and Haemostasis (ISTH) criteria for Lupus Anticoagulant identification and will include prescreening tests, the lupus anticoagulant screening assays and mixing studies if indicated. The inclusion of prescreening tests and mixing studies will help to detect if testing is prolonged due to Lupus Anticoagulant, a possible factor deficiency, direct oral anticoagulant interference, vitamin K antagonist or other inhibitors.

Due to the comprehensive nature of the test, it is imperative that the full amount of required specimen (as per the phlebotomy label) be sent to the Central Lab for processing. Please see updated specifications below.